Infographic: Bitter Pill -- Indian pharma's dependence on China

Over-dependence on low cost imports from China has prevented Indian pharma from being self-reliant, posing a severe health security risk. Even critical APIs, many of which are included in India's national list of essential medicines (NLEM) are being imported from China. This BusinessToday's infographic looks at Indian pharmaceutical sector's heavy reliance on the neighbouring country and what it needs to do to become 'pharmacy to the world'.   

Click here to Enlarge

Also view: How Jio made Reliance net-debt free

Also view: How coronavirus has damaged job scene in India

Also view: How little Govt will spend of Rs 21 lakh cr stimulus package

Also view: Alcohol to the rescue

Also view: Has Sensex bottomed out?

Also view: What crude crash means for India

Also view: How coronavirus has hurt Indian economy

Also view: The Big PPEs shortage in battling coronavirus

Also view: How is coronavirus test done?